Lonza plans 'cell therapy expansion project'

PDA gives company conceptual approval By Jeff McMenemy PORTSMOUTH — Lonza Biologics has received conceptual approval from the Pease Development Authority to move forward with its “cell therapy expansion project.” PDA Board of Director member Peter Loughlin said the...

Heavy metallic elements influence AMD progression

By Lucy Piper, Senior medwireNews Reporter Researchers report associations between age-related macular degeneration (AMD) and five heavy metallic elements, in findings that highlight the detrimental effects of pollution but the possible benefits of essential elements...

New AMD treatments in sight

As the years roll by, one health challenge you may be overlooking is vision loss. Nearly a quarter of Americans 70 and older have serious visual impairment, and the major cause is age-related macular degeneration (AMD). Macular degeneration involves deterioration or...
On